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Overexpression of Laminin-8 in Human
Dermal Microvascular Endothelial Cells
Promotes Angiogenesis-Related Functions
Jie Li1,2,3, Lisa Zhou1,2, Hoang T. Tran1,2, Yi Chen1,2, Ngon E. Nguyen1,2, Marvin A. Karasek1,2
and M. Peter Marinkovich1,2
This study examined the effects of endogenous overexpression of laminin-8 on angiogenesis and wound
healing in primary human dermal microvascular endothelial cells (HDMECs). HDMECs expressed laminin-8 and
laminin-10, but no other laminins, as determined by radioimmunoprecipitation assay using a panel of
antibodies to individual laminin chains. To study laminin-8 function, full-length human laminin a4 cDNA was
retrovirally transferred to HDMEC, and specific overexpression of laminin-8 was verified by Western blot.
Laminin-8 overexpression promoted endothelial cell spreading and migration in scratch assays and accelerated
angiogenic tubule formation in collagen gel overlay assays. Strong inhibitory effect of b1 integrin and weak
inhibition by avb3 integrin antibodies were observed in laminin-8-stimulated cell migration, but only b1 integrin
antibodies affected tubule formation. These studies suggest that laminin-8 overexpression may prove to be a
useful method to engineer HDMECs to promote angiogenesis and wound repair.
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INTRODUCTION
Laminins are a family of large, extracellular heterotrimeric
basement membrane glycoproteins (Timpl and Brown, 1994;
Engvall and Wewer, 1996). Laminins demonstrate specific
tissue distributions, and tissue specificity of laminin function
is achieved through the diversity of combinations of laminin
a, b, and g chains (Burgeson et al., 1994). To date, five a
chains, three b chains, and three g chains have been
identified (Table 1). The a chains contain a globular (G)
domain of about 100 kDa at their C-terminus, which
functions as a primary binding site for integrin cell surface
receptors (Timpl et al., 2000).
Laminins are involved in many important biologic
processes including embryogenesis, tumor invasion, tissue
differentiation and wound healing (Ryan et al., 1996). The
physiologic importance of the laminins in these processes is
illustrated by mutations of laminin genes, which are
associated with human diseases (McGowan and Marinko-
vich, 2000). Gene mutations that affect the a2 chain gene can
lead to muscular dystrophy (Wewer and Engvall, 1996).
Mutations that induce defects of a3, b3, or g2 chains (Uitto
et al., 1997) can result in severe mucocutaneous blistering
diseases (junctional epidermolysis bullosa) (Marinkovich,
1999).
The process of angiogenesis shows many interesting
parallels to the process of epithelial wound healing (Folkman
and Shing, 1992). Each process requires the production of
basement membrane components, spreading and migration
of cells upon these components, and eventual assembly of the
basement membrane after cell migration. Endothelial base-
ment membranes are similar to epithelial basement mem-
branes in that they contain a single predominant large
laminin, laminin-10, as well as a smaller laminin, laminin-8
(Lefebvre et al., 1999; Gonzales et al., 2001; Sixt et al.,
2001). In molecular similarity, laminin-8 (a4b1g1) most
closely resembles laminin-6 (a3b1g1). Each molecule con-
tains the same b1 and g1 chains, and of all laminin chains,
the a4 chain shows the highest sequence homology to the
laminin a3a chain (Liu and Mayne, 1996; Iivanainen et al.,
1997; Richards et al., 1997). Both laminin-6 and laminin-8
adopt a Y shape as shown by rotary shadowing electron
microscopy (Marinkovich et al., 1992a; Kortesmaa et al.,
2000). Like laminin a3 chain, the laminin a4 chain appears to
be processed in the tissue, through proteolytic cleavage at the
junction of the G3–4 domains (Talts et al., 2000).
Laminin-8, in particular its a4 G domain, has been
implicated in the regulation of endothelial cell survival
(DeHahn et al., 2004), as well as endothelial cell migration
and adhesion (Gonzales et al., 2001; Gonzalez et al., 2002),
which occurs in association with the activation of the Rac1
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small GTPase (Fujiwara et al., 2004). While the use of
recombinant laminin a4 G domain fragments in the studies
above has proven informative, studies that address the effects
of endogenous expression of laminin-8 on endothelial cell
function are thus far lacking.
In the work described in this report, we have used a
retroviral vector to generate microvascular endothelial cells
that overexpress the laminin a4 chain, and have character-
ized the isoforms of the laminins synthesized. Using these
cells, we have examined how this overexpression affects
wound healing and angiogenesis in in vitro models. Methods
to increase wound healing and angiogenesis by overexpres-
sion of laminins in vitro may increase our understanding of
how to apply these procedures in vivo when these functions
are defective.
RESULTS
Expression of laminin-8 and -10 by human dermal micro-
vascular endothelial cells
To characterize the endogenous expression of laminins in
human dermal microvascular endothelial cells (HDMECs),
we performed radioimmunoprecipitation studies of condi-
tioned medium from primary cultures of HDMECs, using a
panel of specific laminin antibodies. An antibody to the
laminin a5 chain precipitated only one band of high
electrophoretic migration by non-reduced SDS-PAGE (Figure
1a, lane 1), whereas antibodies to laminin b1 and g1 chains
(Figure 1a, lanes 2 and 3) precipitated two laminin species,
one with high molecular weight, which is same as that
precipitated by laminin a5 antibody. No laminins were
precipitated by antibody to laminin a2 chain or by control
mouse IgG (Figure 1a, lanes 4 and 5). These results
demonstrate that HDMECs produced two forms of laminin,
a higher molecular weight species that contains laminin a5,
b1, and g1 chains, namely laminin-10, and another lower
molecular weight species that contains b1, g1 chains, but not
the a5 or a2 chain.
Table 1. Nomenclature of currently identified laminins
Name Composition Tissue distribution References
Laminin-1 a1, b1, g1 Epithelium Timpl et al. (1979)
Laminin-2 a2, b1, g1 Muscle, nerve Ehrig et al. (1990)
Laminin-3 a1, b2, g1 Neuromuscular junction Hunter et al. (1989)
Laminin-4 a2, b2, g1 Ligaments Engvall et al. (1990)
Laminin-5 a3, b3, g2 Epithelium Marinkovich et al. (1992b)
Laminin-6 a3, b1, g1 Epithelium Marinkovich et al. (1992a)
Laminin-7 a3, b2, g2 Epithelium Champliaud et al. (1996)
Laminin-8 a4, b1, g1 Blood vessels Gonzales et al. (2001)
Laminin-9 a4, b2, g1 Neuromuscular junction Sunderland et al. (2000)
Laminin-10 a5, b1, g1 Epithelium, blood vessels Li et al. (2003) and Miner et al. (1995)
Laminin-11 a5, b2, g1 Epithelium Champliaud et al. (1996)
Laminin-12 a5, b1, g3 Epithelium, muscle Koch et al. (1999)
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Figure 1. (a) Laminin expression in primary HDMECs. Anti-laminin a5 mAb
4C7 (lane 1), anti-laminin g1 mAb 2E8 (lane 2), anti-laminin b1 mAb 545
(lane 3), anti-laminin a2 chain antibody 5H2 (lane 4), or mouse IgG (lane 5)
were used to immunoprecipitate laminins from HDMEC medium. Precipi-
tated proteins were washed extensively, then dissolved in sample buffer
and separated by SDS-PAGE under non-reducing conditions on a 3–5%
acrylamide gel, and then visualized by autoradiography. (b) Western blot
analysis of HDMEC laminins. Conditioned medium of LSV5 keratinocytes
(lanes 1, 4, 6, and 8) or HDMECs (lanes 2, 5, 7, and 9) or HDMEC matrix (lane
3) was separated by non-reduced SDS-PAGE, transferred to nitrocellulose,
and analyzed with the following primary antibodies: human placental
laminin pAb (lanes 1–3), laminin-5/6 pAb (lanes 4 and 5), laminin a4 pAb
(lanes 6 and 7), non-immune rabbit sera (lanes 8 and 9). (c) Reduced
SDS-PAGE analysis of HDMEC laminins. Conditioned medium of HDMECs
was separated on 5% acrylamide gels by reduced SDS-PAGE and analyzed by
Western blot with the following antibodies: human placental laminin pAb
(lane 1), Engelbaeth-Holm-Swarm sarcoma laminin pAb (lane 2), laminin a4
pAb (lane 3), and non-immune rabbit sera (lane 4). (d) Non-reduced Western
blot of conditioned HDMEC-LACZ (control) or HDMEC-a4 (a4) medium using
human placental laminin pAb. Positions of laminin-10 and -8 are shown to
the right.
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To further identify the lower molecular weight laminin,
identified in Figure 1a, conditioned serum-free HDMEC
medium was concentrated and examined by Western blot.
As the lower molecular weight band seen in HDMEC
medium was of the same size as that of laminin-6, we
examined in parallel the serum-free conditioned medium of
LSV5 epithelial cells. These cells fail to produce laminin-5,
but produce laminin-6, which contains an a3 chain, and
which is immunologically distinct but structurally similar to
laminin a4 chain. (Marinkovich et al., 1993). A polyclonal
antibody to human placental laminin, which reacts with
laminin b1 and g1 chains, identified a pair of laminin species
in conditioned medium of each cell type and in HDMEC
matrix (Figure 1b, lanes 1–3). Laminin-5/6 polyclonal anti-
body recognized the lower band in LSV5 medium, identifying
it as laminin-6, but failed to recognize the lower band in
HDMEC medium (Figure 1b, lanes 4 and 5). In contrast, a
polyclonal antibody against the laminin a4 chain recognized
the lower laminin band in HDMEC medium, but not in LSV5
medium (Figure 1b, lanes 6 and 7). These results show that
the smaller laminin species produced by HDMECs contains
an a4, but not an a3 chain.
HDMECs laminins were then analyzed by Western blot
under reducing conditions using several antibodies (Figure
1c). An antibody directed against a whole molecule prepara-
tion of human placental laminin, which was affinity purified
with monoclonal antibody (mAb) 4C7, specific to the laminin
a5 chain, reacts with bands in the 210 and 220 kDa range,
which represent the b1 and g1 laminin chains. In addition,
this antisera reacts with a tight doublet in the 400 kDa range,
which represents laminin a5 chain (Figure 1c, lane 1). A
polyclonal antibody directed against a laminin preparation
from the mouse Engelbaeth-Holm-Swarm sarcoma tumor,
which contains laminin-1, but no laminin-10, recognized b1
and g1 chains in HDMEC medium, but no reactivity in the
400 kDa range could be demonstrated (Figure 1c, lane 2).
Finally, antisera specific to laminin a4 chain recognized an
approximately 200 kDa band in conditioned HDMEC med-
ium (Figure 1c, lane 3). These results show that HDMEC
laminins contain a4b1g1 and a5b1g1 chains, but no
detectable a1, a2, or a3 chains.
Stable overexpression of laminin-8 in primary cultures of
HDMEC
To further evaluate the functional role of laminin-8 in
HDMEC, full-length human laminin a4 or b-galactosidase
cDNA was overexpressed in HDMECs using retroviral
vectors, which have been shown to produce durable
expression in mammalian cells. Using human placental
laminin polyclonal antibody (pAb), Western blot analysis of
HDMECs, overexpressing the full-length laminin a4 cDNA
(HEMEC-a4), revealed an increased expression of laminin-8,
without a significant change in laminin-10 (Figure 1d) or total
protein expression as evaluated by Coomassie Brilliant Blue
staining (not shown).
Effect of laminin-8 overexpression on HDMEC Morphology
Figure 2 illustrates the effect of overexpression of laminin-8
on cell morphology, Factor 8, platelet-endothelial cell
adhesion molecule and collagen synthesis. Normal HDMECs
clearly display two characteristic cell types in cell culture;
epithelioid cells are arranged in islands, which are sur-
rounded by spindle-shaped cells. These two normal cell
populations have been more fully characterized previously
(Lipton et al., 1991). Overexpression of laminin-8 clearly
promoted a population of cells with a uniform epithelioid
morphology (Figure 2b). These cells were transduced with the
laminin a4 chain retroviral vector and selected with
Blasticidin, and considered the pure population harboring
the a4 vector, while control cells transfected with retroviral
vector alone showed typically two types of morphology,
epithelioid and spindle shaped (Figure 2a). PECAM and
Factor 8 expression were equivalent in both control and in
Figure 2. Laminin-8 promotes epithelial morphology of HDMECs. HDMECs
were transduced (b, d, f, and h) with full-length laminin a4 chain sense cDNA
or (a, c, e, and g) with retroviral vector alone as control and selected with
Blasticidin. (a) Phase-contrast photography revealed typical mixture of
epithelioid and spindled cells. (b) Laminin a4 sense-transduced cells were
of epithelioid morphology. Both cell types were examined by
immunohistochemistry using antibodies directed to (c and d) von Willebrand
factor, (e and f) PECAM, and (g and h) type IV collagen. Bar¼20 mm.
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cells overexpressing laminin-8 with the typical decrease in
Factor 8 in spindle-shaped populations (Figure 2c). A major
difference in the two populations is the marked increase in
type IV collagen deposition in the underlying matrix (Figure
2h), suggesting that the synthesis of laminin-8 influences type
IV collagen deposition, a major constituent of the endothelial
basement membrane.
Effects of laminin-8 overexpression on angiogenesis
We further examined the effects of laminin-8 on endothelial
tubule formation (Figure 3a–d). HDMECs-a4 (Figure 3a)
showed a more rapid tubule formation at 4 hours in collagen
overlay assay, compared to control cells (Figure 3b). There
was no significant difference at 24 hours (Figure 3c and d),
suggesting that laminin-8 promotes HDMEC tubule formation
at early stage. The subsequent study of tubule formation
inhibition in HDMECs-a4 using anti-integrin antibodies
revealed that the tubule formation could be partially blocked
by antibodies directed to a2 or a6 integrins at 4 and 8 hours,
and almost completely blocked by using a2 and a6 integrins
together or b1 integrin at 8 hours (Figure 3e–i), indicating that
a2b1 and a6b1 integrins play major roles in promoting
angiogenesis.
Furthermore, laminin-8 overexpression greatly promoted
HDMECs spreading and migration during scratch assays. At
24 hours, HDMECs-a4 consistently filled the gap almost
completely, while control cells consistently failed to cover
most of the scratched surface (Figure 4a–d). To test which
integrin was involved in the process of migration, we added
several integrin-blocking antibodies to the growth medium of
HDMECs-a4 after scratching. The study revealed that the
migration of HDMECs-a4 during wound healing could be
blocked by a6 or b1 integrin antibody, and partially by avb3
antibody (Figure 4e–j), suggesting a6b1 integrin might play an
important role in the migration of HDMECs on laminin-8.
As previous reports have focused mainly on recombinant
a4 G domain in cell-based assays, we wished to determine
whether there were any functional differences between
endogenous full-length whole molecule protein and the G
domain alone. We examined cell migration in a transwell
assay with recombinantly produced a4 G1–3 domain protein
(Figure 5a). The G1–3 is the region of the laminin a4 G
domain, which remains after processing occurs (Talts et al.,
2000). Laminin a4 G domain coated at a concentration of
10 mg/ml supported rapid attachment and spreading of
HDMEC cells (Figure 5b), and the integrins that mediated
this attachment were subsequently analyzed (Figure 5c). The
a3 integrin-blocking antibody showed no effect on attach-
ment, whereas both a2 and a6 antibodies showed partial
inhibition. Approximately 40% inhibition of attachment was
seen with avb3 blocking antibody LM-609, whereas
greater inhibition was noted with b1 integrin antibody
P5D2. The b1 and avb3 inhibitory antibodies combined
together served to totally inhibit HDMEC attachment.
While mAb P5D2 against b1 integrin did not have a
significant inhibiting effect on HDMEC migration, mAb
LM-609 against avb3 integrin blocked migration almost
completely (Figure 5d).
DISCUSSION
As a first step in these studies, it was necessary to verify which
laminins were produced by primary HDMEC and to analyze
their deposition into matrix. Laminin-10 and -8 were both
4 hours 8 hours 24 hours
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Figure 3. (a–d) Laminin-8 promotes HDMEC tubule formation. (a, c)
HDMECs-a4, (b, d) HDMEC-LACZ were evaluated by tubule/vessel formation
collagen overlay assay and observed by phase-contrast microscopy at (a, b)
4 hours and (c, d) 24 hours. (e–i) HDMEC tubule formation via a2b1 and a6b1
integrins. HDMECs-a4 were grown to confluence, and incubated with
integrin antibodies overnight prior to collagen gel overlay and observed at 4,
8, and 24 hours. Antibody of (f) a2 integrin or (g) a6 integrin alone could
partially block tubule formation at 8 hours, (i) b1 integrin alone or (h) a2 and
a6 integrins together could completely block the tubule formation at 8 hours.
Panel e is control with mouse IgG. Bar¼ 200mm.
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produced by these cells, and laminin-8 appeared to be
significantly deposited onto the culture substrate. This is
consistent with previous results, which have shown localiza-
tion of laminin a4 chain in endothelial cell cultures by
indirect immunofluorescent microscopy (Gonzales et al.,
2001). It is possible that sequences on the a4 chain could
enhance interaction with tissue culture plastic or other matrix
molecules. In particular, we noted increased extracellular
type IV collagen deposition in cells overexpressing laminin-8.
The increased deposition of collagen IV is probably due to
the increased deposition of laminin-8. A recent knockout
mouse model showed that the deletion of the laminin a4
chain leads to the dramatically reduced deposition of type IV
collagen and nidogen in the basement membrane zone of
blood vessel and impaired microvessel maturation, suggest-
ing that laminin 8 is required for the organized assembly of
type IV collagen and nidogen into the capillary basement
membrane zone and is a central player in microvessel growth
(Thyboll et al., 2002). An early study found that laminin
appeared before collagen IV (Leivo et al., 1980). In cultured
cells, inactivation of laminin synthesis led to abolished
deposition of type IV collagen and nidogen, failure of
basement membrane zone formation, and loss of cell polarity
(De Arcangelis et al., 1996). It is possible that laminin-8
bound to the cell surface integrin receptor can in turn
stabilize type IV collagen of organization in the extracellular
matrix. Alternatively, laminin-8 binding to its cell surface
ligands could also trigger signaling pathways, which influ-
ence the expression of collagen IV and other extracellular
matrix molecules.
Laminins are large multifunctional proteins, which are
deposited into the basement membrane and into attachment
structures in a precise manner. While studies that examine
laminin-8 deposited onto a culture substrate can be utilized
to explain some aspects of laminin-8 function, it is likely that
more dynamic processes such as migration, and tubule
formation require precise coordination of cell movement and
laminin-8 secretion. Accordingly, studies of laminin-8 over-
expression provide information that may not be obtained
with studies of purified proteins. It is known that laminin a
chain synthesis is the rate-limiting step in the assembly of
several types of laminins, including laminin-1 and laminin-5
(Yurchenco and O’Rear, 1994; Matsui et al., 1995). The
significant overexpression of laminin-8, which we achieved
after transduction of laminin a4 chain cDNA to HDMECs, is
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Figure 5. Functional analysis of recombinant laminin a4 G domain.
(a) Conditioned medium of laminin a4 G domain, expressing 293-EBNA cells
(lanes 1 and 3) or control parental 293-EBNA cells (lanes 2 and 4) was
purified by FLAG antibody affinity chromatography, separated by SDS-PAGE,
and stained with Coomassie Blue total protein stain (lanes 1 and 2) or with
anti-laminin a4 pAb (lanes 3 and 4). (b) Improved spreading and flattening of
HDMECs on G1–3 coated culture surfaces. (c) The attachment of endothelial
cells to laminin a4G domain via b1 and avb3 integrins. The
96-well plates were pre-coated with 10 mg/ml laminin a4G1-3 domain protein
or BSA as control, and then utilized in HDMEC colorimetric cell attachment
assays in the presence of 15 mg/ml of each of the various integrin-blocking
antibodies as indicated under the bars. The attached cells were stained with
0.1% crystal violet and analyzed by colorimetric measurement at OD570.
(d) Laminin a4 G domain promotes HDMEC migration via avb3 integrin. The
bottoms of Costar migration chamber were pre-coated with BSA (left bar) or
laminin a4 G1-3 protein (all other condition shown on the right), HDMECs
were then plated on the top of the migration chambers and immerged in the
growth medium containing mouse IgG 15mg/ml (control) or the indicated
antibodies at the same concentration, and cells were counted in the lower
chamber after 24 hours.
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Figure 4. (a–d) Laminin-8 promotes HDMEC migration. (b, d) HDMEC-a4 or
(a, c) HDMEC-LACZ were grown to confluence in 35 mm dishes. Cross-
shaped scratches were made and cells were analyzed at (a, b) 0 and (c, d)
24 hours. (e–j) Antibody inhibition of HDMEC migration. HDMEC-a4 cells
were evaluated by scratch assay at (e) 0 or (f–j) 24 hours in the presence of
inhibitory antibodies to integrins (g) a6, (h) avb3, (i) b1, (j) b1 and avb3
together or (b) mouse IgG. Bar¼200 mm.
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consistent with the hypothesis that laminin a4 chain
expression is the rate-limiting step in laminin-8 synthesis.
The role of laminins in tubule formation has been
previously studied, when it was believed that laminin-1 was
the primary endothelial laminin (Grant et al., 1994). The
current study is the first to show that laminin-8 promotes
tubule formation in endothelial cells. In this process, a2b1
and a6b1 integrins appear to play a significant role, as
evidenced by our antibody inhibition studies. Thus, several
stages of angiogenesis appear to be significantly influenced
by laminin-8, including cell attachment, cell migration and
tubule formation. Targeting of laminin a chains in inducing
overexpression may be of use in future applications of genetic
therapy in vivo.
Previous studies have produced some conflicting results,
showing either that endothelial cells bind to laminin-8 via
b1-containing integrins (Kortesmaa et al., 2000; Talts et al.,
2000), or that avb3 integrin is the primary receptor for
laminin-8 in endothelial cells (Gonzales et al., 2001). From
our studies, it is clear that HDMECs utilize both b1 integrins
as well as avb3 integrin in their interactions with laminin-8.
Specifically, each of the integrins binds to the region of the
G1–3 domain of the a4 chain. In the case of migration, we
have certainly been able to show changes in the utilization of
the two principal laminin-8 binding integrins, on purified
versus endogenously synthesized laminin-8. While avb3
integrin appears to play the more important role in HDMEC
migration on purified laminin-8 a4 G domain in the transwell
chambers, a6b1 integrin appears to play a more significant
role in the utilization of endogenously synthesized laminin-8
during scratch migration assays. Other studies have suggested
that recombinant a4 G domain does not have identical
functional properties compared to the native laminin-8
molecule (Talts et al., 2000). It is possible that the endogenous
laminin whole molecule has different tertiary structural
conformation, compared with a4 G domain alone, and that a
cooperative interaction of these integrins, in a process such as
cell migration, occurs only on native full-length laminin-8.
MATERIALS AND METHODS
Antibodies
Polyclonal antibodies directed to human placental laminin b1 and
g1 chain complex were purchased from Chemicon International Inc.
(Temecula, CA). mAbs 4C7, 545, and 2E8, directed against human
laminin a5, b1, and g1 chain, respectively, were generously donated
by Dr Eva Engvall (Burnam Institute, La Jolla, CA). Type IV collagen
mAb was purchased from Research and Diagnostic Systems
(Berkeley, CA), von Willebrand factor antibody from DAKO
Corporation (Carpinteria, CA), and PECAM-1 antibody from Endogen
(Woburn, MA). Antibody specific against laminin a4 chain (Pierce
et al., 1998) was kindly provided by Dr Jeff Miner (Washington
University, St Louis, MO). Human placental laminin pAb were
purchased from Chemicon (Temecula, CA); laminin-5/6 pAb,
Engelbaeth-Holm-Swarm sarcoma laminin pAb was described
previously (Marinkovich et al., 1992b). The antibodies used for
different laminin chains are summarized in Table 2. mAbs against
various integrin subunits including a2 (clone P1E6), a6 (clone
GoH3), b1 (clone P5D2), and avb3 (clone LM-609) were purchased
from Chemicon International Inc. For integrin antibody-blocking
analyses in our cell-based assays, we used a concentration of 15mg/
ml. A variety of reported studies including our own experiences
indicate that maximal integrin antibody inhibition is usually
achieved in the range of 10–15mg/ml (Russell et al., 2003). We
tried a higher concentration of 30 mg/ml for our antibodies and did
not see any additional inhibitory effect.
Cell cultures
Primary HDMECs were isolated from neonatal human foreskin from
normal circumcisions as described previously (Normand and
Karasek, 1995). Foreskin tissues were obtained using an exempted
protocol approved by Stanford University Institutional Review Board
and in accordance with the Declaration of Helsinki Principles.
HDMECs were cultured in 1% gelatin-coated tissue culture dishes
and maintained in a 371C, 5% CO2 incubator with Iscove’s medium
from Gibco BRL (Grand Island, NY) supplemented with 8% fetal
bovine serum, 2% human prepartum maternal serum, 2.0 104 M
dibutyryl cyclic adenosine monophosphate, 3.0 105 M isobutyl
methylxanthine, 0.84 104 M hypoxanthine, and 1.33 105 M
thymidine. At passage 1, HDMECs were purified through Ulex
europeus-coated Dynal beads according to the manufacturer’s
instruction (Dynal Inc., NY), with greater than 95% of purity were
achieved as determined by staining for von Willebrand factor,
PECAM, and type IV collagen. Third to fourth passage HDMECs were
used for the experiments. LSV5 cells were cultured in serum-free
keratinocyte growth medium (Clonetics, San Diego, CA) and were
generously provided by Dr Jean-Paul Ortonne, Nice, France. LSV5
cells are an SV40 virus-immortalized cell line of skin keratinocytes,
from an epidermolysis bullosa patient, which do not produce
laminin-8 and -10 and are deficient in laminin-5 protein but have
increased the secretion of laminin-6 (Miquel et al., 1996).
Immunostaining for endothelial cell marker expression
The expression of several antigens in HDMECs was examined by
immunostaining with specific antibodies as described previously
Table 2. Summary of antibodies used for laminins
or laminin chains
Antigen Antibody Resource/reference
b1 and g1 chain pAb placental laminin Chemicon
a5, b1, g1 chain pAb placental laminin Chemicon
a4 chain pAb a4 Pierce et al. (1998)
Laminin-1 (a1, b1, g1) pAb
Engelbaeth-Holm-Swarm
sarcoma laminin
Research diagnostics
Laminin-5(a3, b3, g2) pAb laminin 5/6 Marinkovich et al.
(1992b)
Laminin-6(a3, b1, g1) pAb laminin 5/6 Marinkovich et al.
(1992a)
a5 chain mAb 4C7 Tiger et al. (1997)
b1 chain mAb 545 Marinkovich et al.
(1992a)
g1 chain mAb 2E8 Engvall et al. (1986)
a2 chain mAb 5H2 Leivo et al. (1989)
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(Zhou et al., 2000). Briefly, cells were fixed in 100% cold methanol
for 20 minutes, blocked with 3% H2O2 for 30 minutes to inhibit
endogenous peroxidase activity, and incubated with primary
antibodies at 41C overnight. Immunoperoxidase activity was
determined using the Vectastain ABC kit and VIP kit (Vector Lab.
Inc., Burlingame, CA) according to manufacturer’s instruction. A
Zeiss Axioskop II microscope with a digital camera (Zeiss,
Hallbergmoos, Germany) was used to capture the images. The
quantitation was performed using Zeiss molecular image system
AxioVision 3.0 software (issued 10/2,000). A total of 18 areas were
analyzed for each condition (two independent cultures were used for
each condition, three pictures were taken for each culture, and three
areas were analyzed for each picture). The intensity of staining was
expressed as mean gray scale value of the staining per pixel (or
square picture element). Statistical differences between groups were
determined by Student’s t-test. P-value o0.05 is considered as
significant.
Immunoprecipitation assay
Purified HDMECs were pulse labeled with 35S methionine/cysteine
(Amersham Biosciences, Piscataway, NJ) in methionine- and
cysteine-deficient medium, and conditioned medium was collected
and immunoprecipitated with antibodies directed to laminin
subunits: laminin a5 mAb 4C7, laminin g1 mAb 2E8, laminin b1
mAb 545, laminin a2 chain mAb 5H2, or mouse IgG as control.
Precipitated proteins were washed, dissolved in sample buffer, and
separated by SDS-PAGE under non-reducing conditions on a 3–5%
acrylamide gel, and then visualized by autoradiography (Marinko-
vich et al., 1992b).
Transduction of endothelial cells using retroviral vector
Full-length human laminin a4 cDNA was assembled from over-
lapping cDNA clones generously donated by Drs Alan Richards and
Michael Pope (Strangeway Research, Cambridge, UK) and ligated
into retroviral vector Lazarus retrovirus, which carries a Blasticitin
resistance gene as a selection marker (Deng et al., 1998). Endothelial
cells were grown to 20–40% confluence in six-well culture plate and
retrovirally transduced with LACZ (b-galactosidase) cDNA (Deng
et al., 1998) or full-length laminin a4 cDNA. Briefly, the cells were
incubated in the growth medium supplemented with 5 mg/ml of
polybrene for 10 minutes prior to infection, overlaid 3 ml/well of
viral supernatant supplemented with 5 mg/ml of polybrene, centri-
fuged at 321C, 1,000 r.p.m. for 1 hour, incubated at 321C for
additional 2 hours, and then replaced with fresh growth medium. At
48–72 hours after infection, cells were selected with 5 mg/ml of
Blasticidin for 5–7 days until it reached 100% pure population
harboring the viral structure (as indicated by no viable cells
remaining in normal control dish). The initial positive transduction
before selection, at an efficiency of 35–40%, and pure positive
population after selection were confirmed by staining for b-galacto-
sidase activity in the vector. The expression of laminin-8 was confirmed
by Western blot analysis.
Endothelial cell scratch assay
Scratch migration assay was performed as previously described
(Russell et al., 2003) with the following modifications. Cells were
grown to confluency in a six-well culture plate. Then, a cross-shaped
wound (no cell zone) was made by a uniformly placed scratch
among the cells with a pipette tip. The floating cells or cells
detached from the dish by scratch were washed off and the
remaining cells were continually incubated with growth medium
in the presence of mitomycin C at 10 mg/ml (Sigma, St Louis, MO).
For the antibody inhibition assay, antibodies were added to the
growth medium immediately after scratch. The migration of the cells
(or the gap filling) was recorded at 12, 24, and 36 hours (only
showed 24 hours as representative) through a phase-contrast micro-
scopy, quantified by the time and percentage of the wound gap
covered by the cells that migrated in and filled up the gap, and
quantified using NIH image software Image J Program (public
domain, http://rsb.info.nih.gov/ij/). The center of the cross (where the
two scratch lines meet) was used for the positioning. Three
independent experiments were performed with each in duplicates,
a total of six measurements was obtained for each treatment. The
results were analyzed by Student’s t-test. P-value p0.05 was
significant.
Endothelial cell tubule formation/collagen gel overlay assay
Endothelial cell tubule formation was adapted from a previous
method (Kubota et al., 1988), with minor modifications. Confluent
endothelial cells cultured in six-well plate were overlaid with 2 ml of
collagen solution of 1:1 mixture of Vitrogen 100 (Angiotech
BioMaterials, Palo Alto, CA) and 2 Iscove’s medium (Life
Technologies Inc., Carlsbad, CA) and neutralized with 0.5 N NaOH.
Solidification of the collagen gel occurred after incubation at 371C
for 30 minutes. Tubule formations were observed at 0, 4, 8, and
24 hours time points. For tubule formation inhibition assay,
antibodies directed against various integrins were added to the cell
culture medium at 15 mg/ml 14 hours prior to the collagen overlay
assay.
Recombinant laminin a4 subdomain expression and purification
Subdomain construct of laminin a4G1–3 was produced in a
mammalian expression system utilizing 293 kidney epithelial cells.
The vector, pCEP-Pu/Flag, originally from pCEP4 (Invitrogen,
Carlsbad, CA), is a puromycin-resistant EBNA episomal vector and
engineered to produce an 8-amino-acid Flag-tag. The transfection
was performed with Lipofectamine (GibcoBRL) according to the
manufacturer’s instruction. After 48 hours, the cells were selected
with 10 mg/ml of puromycin, and stable transfectants were used for
protein expression. The expressed and secreted fusion protein was
collected from cell growth medium and purified through an anti-Flag
antibody affinity column according to the manufacturer’s instruction
(Sigma). The purified protein was confirmed by Western blot with
anti-Flag polyclonal antibody (Sigma).
Laminin a4G1–3 protein was used at a concentration of 10 mg/ml
for cell attachment and transwell migration assays. Previous reported
studies (Russell et al., 2003) including our own experiences indicate
that optimal cell attachment or migration is usually achieved when
coating with the protein at 10mg/ml overnight. Lower protein
concentration would result in the less cell adhesion or migration,
while no significant increase was observed with higher concentra-
tions.
Endothelial cell transwell migration assay
Eight micrometer pore size Costar transwell migration chambers
(Corning, NY) in 24-well plate were used for migration analysis with
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laminin a4 G domain protein. Briefly, the bottom of each chamber
was pre-coated with 250 ml of protein solution at concentration of
10 mg/ml and incubated at 41C overnight. Subsequently, remaining
protein-binding sites were blocked with 0.5 ml/chamber of 50 mg/ml
BSA in both the top and bottom of the chamber. Then, 750 ml of
medium was added to each well, and 100 ml of endothelial cells at
2 106/ml was plated on the top of the chamber and incubated at
371C for desired time period. For the migration-blocking assay,
blocking antibody was added to the medium at 15 mg/ml prior to
plating the cells. Cells were fixed with 3% paraformaldehyde at
room temperature for 15 minutes and stained with 0.1% crystal
violet. The stain was rinsed off thoroughly with water, cells
remaining in the top of the migration chamber were removed by
lightly swabbing, and stained cells adhering to the coated bottom of
the chamber were counted under a phase-contract microscope. The
results were analyzed by Student’s t-test. P-valuep0.05 was significant.
Endothelial cell attachment assay
The 96-well plates were pre-coated with 100 ml/well of protein
solution of 10 mg/ml at 41C overnight and blocked with 100ml of
20 mg/ml BSA in phosphete-buffered saline at 371C for 1 hour. Then,
HDMECs of 100 ml/well at 6 105/ml were added to plate and
incubated at 371C. One hour later, medium and floating cells were
removed, and attached cells were fixed with 1.25% glutaraldehyde
solution for 20 minutes at room temperature, stained with 0.1%
crystal violet, solubilized with 100 ml/well of 10% acetic acid for
10 minutes, and the colorimetric reading at optical density 570 was
measured with a spectrophotometric plate reader. For antibody-
blocking assay, cells were incubated with blocking antibodies at
15 mg/ml for 20 minutes prior to the plating.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was funded through the Office of Research and Development, Palo
Alto Veterans Affairs Health Care Service, NIH Grants P01 AR 44-012 and
R01-47223-01 (M.P.M.) as well as NIH F32 AR08576 and R03 AR048648
(J.L.) and a grant from the Ludwig Foundation (M.A.K.).
REFERENCES
Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H et al.
(1994) A new nomenclature for the laminins. Matrix Biol 14:209–11
Champliaud MF, Lunstrum GP, Rousselle P, Nishiyama T, Keene DR,
Burgeson RE (1996) Human amnion contains a novel laminin variant,
laminin 7, which like laminin 6, covalently associates with laminin 5 to
promote stable epithelial–stromal attachment. J Cell Biol 132:1189–98
De Arcangelis A, Neuville P, Boukamel R, Lefebvre O, Kedinger M, Simon-
Assmann P (1996) Inhibition of laminin alpha 1-chain expression leads
to alteration of basement membrane assembly and cell differentiation.
J Cell Biol 133:417–30
DeHahn KC, Gonzales M, Gonzalez AM, Hopkinson SB, Chandel NS,
Brunelle JK et al. (2004) The alpha4 laminin subunit regulates
endothelial cell survival. Exp Cell Res 294:281–9
Deng H, Choate KA, Lin Q, Khavari PA (1998) High-efficiency gene transfer
and pharmacologic selection of genetically engineered human kerati-
nocytes. Biotechniques 25:274–80
Ehrig K, Leivo I, Argraves WS, Ruoslahti E, Engvall E (1990) Merosin, a tissue-
specific basement membrane protein, is a laminin-like protein. Proc Natl
Acad Sci USA 87:3264–8
Engvall E, Davis GE, Dickerson K, Ruoslahti E, Varon S, Manthorpe M (1986)
Mapping of domains in human laminin using monoclonal antibodies:
localization of the neurite promoting site. J Cell Biol 103:2457–65
Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR (1990)
Distribution and isolation of four laminin variants; tissue restricted
distribution of heterotrimers assembled from five different subunits. Cell
Regul 1:731–40
Engvall E, Wewer UM (1996) Domains of laminin. J Cell Biochem
61:493–501
Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–4
Fujiwara H, Gu J, Sekiguchi K (2004) Rac regulates integrin-mediated
endothelial cell adhesion and migration on laminin-8. Exp Cell Res
292:67–77
Gonzalez AM, Gonzales M, Herron GS, Nagavarapu U, Hopkinson SB,
Tsuruta D et al. (2002) Complex interactions between the laminin alpha
4 subunit and integrins regulate endothelial cell behavior in vitro and
angiogenesis in vivo. Proc Natl Acad Sci USA 99:16075–80
Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB
et al. (2001) Structure and function of a vimentin-associated matrix
adhesion in endothelial cells. Mol Biol Cell 12:85–100
Grant DS, Kibbey MC, Kinsella JL, Cid MC, Kleinman HK (1994) The role of
BMZ in angiogenesis and tumor growth. Path Res Pract 190:854–63
Hunter DD, Shah V, Merlie JP, Sanes JR (1989) A laminin-like adhesive
protein concentrated in the synaptic cleft of the neuromuscular junction.
Nature 338:229–34
Iivanainen A, Kortesmaa J, Sahlberg C, Morita T, Bergmann U, Thesleff I et al.
(1997) Primary structure, developmental expression, and immunoloca-
lization of the murine laminin alpha4 chain. J Biol Chem 272:27862–8
Koch M, Olson PF, Albus A, Jin W, Hunter DD, Brunken WJ et al. (1999)
Characterization and expression of the laminin gamma3 chain: a novel,
non-basement membrane-associated, laminin chain. J Cell Biol
145:605–18
Kortesmaa J, Yurchenco P, Tryggvason K (2000) Recombinant laminin-8
(alpha(4)beta(1)gamma(1)). Production, purification, and interactions
with integrins. J Biol Chem 275:14853–9
Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and
basement membrane in the morphological differentiation of human
endothelial cells into capillary-like structures. J Cell Biol 107:1589–98
Lefebvre O, Sorokin L, Kedinger M, Simon-Assmann P (1999) Developmental
expression and cellular origin of the laminin alpha2, alpha4, and alpha5
chains in the intestine. Dev Biol 210:135–50
Leivo I, Engvall E, Laurila P, Miettinen M (1989) Distribution of merosin, a
laminin-related tissue-specific basement membrane protein, in human
Schwann cell neoplasms. Lab Invest 61:426–32
Leivo I, Vaheri A, Timpl R, Wartiovaara J (1980) Appearance and distribution
of collagens and laminin in the early mouse embryo. Dev Biol 76:100–14
Li J, Tzu J, Chen Y, Zhang YP, Nguyen NT, Gao J et al. (2003) Laminin-10 is
crucial for hair morphogenesis. EMBO J 22:2400–10
Lipton BH, Bensch KG, Karasek MA (1991) Microvessel endothelial cell
transdifferentiation: phenotype characterization. Differentiation
46:117–33
Liu JG, Mayne R (1996) The complete cDNA coding sequence and tissue-
specific expression of the mouse laminin alpha4 chain. Matrix Biol
15:433–7
Marinkovich MP (1999) Update on inherited bullous dermatoses. Dermatol
Clin 17:473–85, vii
Marinkovich MP, Lunstrum GP, Burgeson RE (1992b) The anchoring filament
protein kalinin is synthesized and secreted as a high molecular weight
precursor. J Biol Chem 267:17900–6
Marinkovich MP, Lundstrum GP, Keene DR, Burgeson RE (1992a) The
dermal–epidermal junction of human skin contains a novel laminin
variant. J Cell Biol 119:695–703
Marinkovich MP, Verrando P, Keene DR, Meneguzzi G, Lunstrum GP,
Ortonne JP et al. (1993) The basement membrane proteins kalinin and
nicein are structurally and immunologically identical. Lab Invest
69:295–9
www.jidonline.org 439
J Li et al.
Overexpression of Laminin-8 in HDMECs
Matsui C, Wong CK, Nelson CF, Bauer EA, Hoeffler WK (1995) The assembly
of laminin 5 subunits. J Biol Chem 270:23496–503
McGowan KA, Marinkovich MP (2000) Laminins and human disease. Microsc
Res Technol 51:262–79
Miner JH, Lewis RM, Sanes JR (1995) Molecular cloning of a novel laminin
chain, alpha5, and widespread expression in adult mouse tissues. J Biol
Chem 270:28523–6
Miquel C, Gagnoux-Palacios L, Durand-Clement M, Marinkovich P,
Ortonne JP, Meneguzzi G (1996) Establishment and characterization of
cell line LSV5 that retains the altered adhesive properties of
human junctional epidermolysis bullosa keratinocytes. Exp Cell Res
224:279–90
Normand J, Karasek MA (1995) A method for the isolation and serial propa-
gation of keratinocytes, endothelial cells, and fibroblasts from a single
punch biopsy of human skin. In vitro Cell Dev Biol Anim 31:447–55
Pierce RA, Griffin GL, Mudd MS, Moxley MA, Longmore WJ, Sanes JR et al.
(1998) Expression of laminin a3, a4, and a5 chains by alveolar epithelial
cells and fibroblasts. Am J Respir Cell Mol Biol 19:237–44
Richards A, Luccarini C, Pope FM (1997) The structural organisation of
LAMA4, the gene encoding laminin a4. Eur J Biochem 248:15–23
Russell AJ, Fincher EF, Millman L, Smith R, Vela V, Waterman EA et al. (2003)
Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through
differential GTPase activation and antagonism of alpha 3 beta 1 integrin.
J Cell Sci 116:3543–56
Ryan MC, Christiano AM, Engvall E, Wewer UM, Burgeson RE (1996) The
functions of laminins: lessons from in vivo studies. Matrix Biol
1996:369–81
Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM (2001)
Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles
in T cell recruitment across the blood–brain barrier in experimental
autoimmune encephalomyelitis. J Cell Biol 153:933–46
Sunderland WJ, Son YJ, Miner JH, Sanes JR, Carlson SS (2000) The presynaptic
calcium channel is part of a transmembrane complex linking a synaptic
laminin (alpha4beta2gamma1) with non-erythroid spectrin. J Neurosci
20:1009–19
Talts JF, Sasaki T, Miosge N, Gohring W, Mann K, Mayne R et al. (2000)
Structural and functional analysis of the recombinant G domain of the
laminin alpha4 chain and its proteolytic processing in tissues. J Biol
Chem 275:35192–9
Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A et al. (2002)
Deletion of the laminin alpha4 chain leads to impaired microvessel
maturation. Mol Cell Biol 22:1194–202
Tiger CF, Champliaud MF, Pedrosa-Domellof F, Thornell LE, Ekblom P,
Gullberg D (1997) Presence of laminin alpha5 chain and lack of laminin
alpha1 chain during human muscle development and in muscular
dystrophies. J Biol Chem 272:28590–5
Timpl R, Brown JC (1994) The laminins. Matrix Biol 14:275–81
Timpl R, Rohde H, Robey Gehron P (1979) Laminin-a glycoprotein from
basement membranes. J Biol Chem 254:9933–7
Timpl R, Tisi D, Talts JF, Andac Z, Sasaki T, Hohenester E (2000) Structure and
function of laminin LG modules. Matrix Biol 19:309–17
Uitto J, Pulkkinen L, McLean WH (1997) Epidermolysis bullosa: a spectrum of
clinical phenotypes explained by molecular heterogeneity. Mol Med
Today 3:457–65
Wewer UM, Engvall E (1996) Merosin/laminin-2 and muscular dystrophy.
Neuromusc Disord 6:409–18
Yurchenco PD, O’Rear JJ (1994) Basement membrane assembly. In: Methods
of enzymology (Ruoslahti E, Engvall E, eds). Vol. 245. Academic Press
Inc.: San Diego, 489–518
Zhou L, Dosanjh A, Chen H, Karasek M (2000) Divergent effects of
extracellular oxygen on the growth, morphology, and function of human
skin microvascular endothelial cells. J Cell Physiol 182:134–40
440 Journal of Investigative Dermatology (2006), Volume 126
J Li et al.
Overexpression of Laminin-8 in HDMECs
